Current Pharmaceutical Design
Title: Editorial [Hot Topic: Prodrugs: Pharmaceutical Design and Current Perspectives (Executive Guest Editor: Josef Jampilek)]
Volume: 17 Issue: 32
Author(s): Josef Jampilek
Affiliation:
Export Options
About this article
Cite this article as:
Jampilek Josef, Editorial [Hot Topic: Prodrugs: Pharmaceutical Design and Current Perspectives (Executive Guest Editor: Josef Jampilek)], Current Pharmaceutical Design 2011; 17 (32) . https://dx.doi.org/10.2174/138161211798194503
DOI https://dx.doi.org/10.2174/138161211798194503 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Article Metrics

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Structure and Functional Relationships of Hsp90
Current Cancer Drug Targets Targeting Heparan Sulfate Proteoglycans and their Modifying Enzymes to Enhance Anticancer Chemotherapy Efficacy and Overcome Drug Resistance
Current Medicinal Chemistry Patent Selections
Recent Patents on Drug Delivery & Formulation ATP-Binding Cassette Transporters in Inflammatory Brain Disease
Current Pharmaceutical Design Meet Our Editorial Board Member
Current Cancer Drug Targets Chemoradiotherapy in Locally Advanced, Unresectable Non-Small Cell Lung Cancer
Reviews on Recent Clinical Trials Suppression of Inflammatory and Allergic Responses by Pharmacologically Potent Fungus Ganoderma lucidum
Recent Patents on Inflammation & Allergy Drug Discovery Indoleamine 2,3-dioxygenase (IDO): Biology and Target in Cancer Immunotherapies
Current Cancer Drug Targets Doxorubicin-Loaded Micelle Targeting MUC1: A Potential Therapeutic for MUC1 Triple Negative Breast Cancer Treatment
Current Drug Delivery Metabolomics: A Revolution for Novel Cancer Marker Identification
Combinatorial Chemistry & High Throughput Screening Deubiquitinating Enzyme Inhibitors and their Potential in Cancer Therapy
Current Cancer Drug Targets The Effects of Statin Therapy on the Human Airway
Drug Metabolism Letters Editorial (Hot Topic: Targeted Therapy of Malignant Brain Tumors)
Current Signal Transduction Therapy Evaluation of Pyrano[3,2 C] Quinoline Analogues as Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Nanocarriers for Respiratory Diseases Treatment: Recent Advances and Current Challenges
Current Topics in Medicinal Chemistry Prediction of Gene Co-Expression by Quantifying Heterogeneous Features
Current Bioinformatics Scope and Limitations of The Co-Drug Approach to Topical Drug Delivery
Current Pharmaceutical Design Reflecting Back to Bring Nitric Oxide Research to the Laboratory
Current Medicinal Chemistry Methodological Issues of Clinical Research with EGFR Inhibitors
Current Cancer Therapy Reviews HSP90 Inhibitors: Current Development and Potential in Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery